In ovarian cancer SK-OV-3 cells, XAP enhanced the antiproliferative and proapoptotic effects of PTX on tumor cells and inhibited PTX-induced PXR and the antiapoptotic protein Bcl-2, exerting antitumor effects and inhibiting the malignant progression of ovarian cancer. This evidence concerns the gene BCL2 and ovarian cancer.